BPO 0.00% 0.3¢ bioprospect limited

nice, page-5

  1. 3,267 Posts.
    Yesterday's quarterly report for the period ended 31March was a basic summary which covered conservatively the exciting path BPO is on.It should have outlined the nature of the relationships and the background of who they are with. There hasn't been anything factored into the sp from the partnership with Solagran. There's not much for sale between 4.5 c and 5.
    Once the media and brokers get an appreciation of BPO and the Solagran relationship it should carry BPO higher with so few sellers. There is about 9 million shares in the market buy orders between 4 and 4.5 c which builds a pretty favourable momentum position.
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.